Study Summary:
Parkinson’s Disease (PD) affects an estimated 4-6 million people and their families all over the world. While there is still no cure, participating in clinical trials can help future generations better understand and develop treatments for this debilitating condition.
Researchers at approximately 98 clinics around the world are conducting a research study to test how effective an investigational medication might be in treating certain side effects caused by levodopa (L-dopa) treatment. Different dose levels of the study medication will be compared to placebo (looks like the investigational medication but does not contain the active ingredient) and Rasagiline (an approved medicine) when added to L-dopa.
Qualified Participants Must:
• Be 30 to 85 years of age
•
Be taking levodopa (L-dopa) medication for Parkinsons’s Disease for 1 year or longer. Please note that you will stay on this medication while participating.
•
Be experiencing motor fluctuations (medication “off” time) and jerky, dance-like movements of the arms and/or head (dyskinesias) for the last month or longer
Qualified Participants May Receive:
Study-related medication and study-related procedures at no cost.